Clinical Trial: Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic HER2-Negative Breast Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Randomized Clinical Trial Comparing ctDNA-Directed Therapy Change With Standard of Care in Patients With Metastatic Triple Negative Breast Cancer
Brief Summary:
This phase II trial tests how well evaluating circulating tumor deoxyribonucleic acid (ctDNA) works to guide therapy-change decisions in treating patients with triple-negative breast cancer (TNBC) that has spread from where it first started (primary site) to other places in the body (metastatic).This study wants to learn if small pieces of DNA associated with a tumor (called circulating tumor DNA, or ctDNA) can be detected in investigational blood tests during the course of standard chemotherapy treatment for…
Read more